Randomized trial of intraoperative intercostal block with bupivacaine with epinephrine compared to lipossomal extended release bupivacaine.
Patients undergoing minimally invasive thoracic surgery will be randomized to receive 0.05% bupivacaine with 1:200,000 epinephrine (control group) or extended release lipossomal bupivacaine. Primary outcomes are postoperative pain measured by visual analog scale, amount of morphine equivalent narcotics used, and postoperative complications. Patients are excluded if they undergo open thoracotomy, or minimally invasive decortication.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Methodist University Hospital
Memphis, Tennessee, United States
RECRUITINGPostoperative pain
Pain assessment with Visual Analog Scale (VAS). This is a numeric pain scale widely used in healthcare that ranks pain from 0 (no pain) to 10 (unbearable pain). A pain score below 3 is considered good.
Time frame: 3-5 days post op
Postoperative complications
Any complication occuring in the first 90 days classified according to the Clavien-Dindo classification.
Time frame: 90 days post op
Narcotic used
Amount of morphine equivalent dosage used in the postoperative period
Time frame: 3-5 days post op
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.